Investor Presentation

119 Investor presentation First six months of 2022 GLP-1 market share and market growth in Region China Region China 160% 120% 80% 40% GLP-1 market growth and Novo Nordisk market share 0% May 2019 GLP-1 market size and growth 160% DKK billion 119% 120% 80% 63% 1 63% 40% 45% 85% 1 ~119% 1 0 2 -63% 63% 0% May 2022 May Novo Nordisk Eli Lilly Others May 2021 2022 Novo Nordisk Competitors NN market share -Market growth (right axis) NN share of growth NN growth (right axis) Source: IQVIA,May2022, Value, MAT; NN: Novo Nordisk; Region China covers Mainland China, Taiwan, and Hong Kong

View entire presentation